CHICAGO, March 26 — Harvard Medical School researchers are working on a new, simpler way to distinguish malignant tumors from non-cancerous masses when screening for breast cancer.Scientists in the laboratory of Dr. John Frangioni, M.D., Ph.D., associate professor of medicine and radiology at Harvard Medical School, have developed a contrast agent that selectively targets and highlights malignant micro-calcifications in the breast, while ignoring similar micro-calcifications found in benign breast conditions.>>> Discuss This Story
